15. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies

BACKGROUND: Infectious complications in cancer patients (pts) who have received T-cell therapies are similar to those in autologous hematopoietic stem cell transplant (HCT) recipients, who - because they lose prior acquired immunity after undergoing conditioning regimens and transplantation- may be...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelidakis, Georgios, Chemaly, Roy F, Kebriaei, Partow, Ajami, Nadim J, Bhatti, Micah M, Shpall, Elizabeth, Hosing, Chitra, Jain, Preetesh, Mahadeo, Kris Michael, Khawaja, Fareed, Wargo, Jennifer, Jenq, Robert, Heredia, Ella Ariza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644806/
http://dx.doi.org/10.1093/ofid/ofab466.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644806/
http://dx.doi.org/10.1093/ofid/ofab466.217

Ejemplares similares